TJP, an independent agency specializing in value and patient access for life sciences, and strategy-led creative for consumer brands, today announced its acquisition of Evolution Consulting & Research, a premier life sciences market research organization.
The acquisition marks another major milestone in TJP's strategic growth, establishing an integrated, end-to-end engine that encompasses Research, Strategy, Creative, Pull-Through, and Analytics. Following the earlier addition of FX2 Virtual — which incorporated Virtual Sales Professionals, Virtual Key Account Managers (vKAMs), reimbursement specialists, and omnichannel data analytics — the inclusion of Evolution Consulting & Research rounds out TJP's platform, giving life sciences clients seamless continuity from upfront market research to field-level commercial execution.
The combination establishes a cohesive commercial continuum for pharmaceutical and biotechnology partners navigating increasingly complex market access and pricing environments. By harmonizing primary research, access strategy, creative campaigns, virtual sales execution, and advanced analytics, TJP delivers an integrated model designed to optimize brand performance, maximize ROI, and accelerate patient access to life-changing therapies.
"Bringing Evolution Consulting & Research into the TJP family fulfills our vision of offering a unified, end-to-end platform," said Rino Mariconda, CEO of TJP and Operating Partner at Renovus Capital Partners. "We entered this year with foundational, strategy-led creative and access capabilities. By integrating FX2 Virtual's commercial deployment infrastructure and now Evolution's high-caliber, best-in-class market research expertise, we have bridged the gap from early clinical and commercial insights to active market pull-through. Our clients can now partner with a single organization to uncover vital market insights, formulate strategy, craft compelling narratives, and execute field pull-through with measurable impact."
Market research delivers the greatest value when insights directly shape strategy and commercial execution. The acquisition aligns Evolution's deep market research capabilities with TJP's existing strengths in access strategy, creative excellence, and virtual field execution.
"Joining forces with TJP and Renovus Capital Partners represents an exciting new chapter for Evolution and our clients," said Mike Heasley, Partner of Evolution Consulting & Research. "Market research delivers the greatest value when insights directly shape strategy, creative execution, and downstream commercial pull-through. By aligning our deep market research capabilities with TJP's access strategy, creative excellence, and virtual field execution teams, we are creating an agency capable of supporting life sciences brands across every stage of their lifecycle."
The strategic move enhances TJP's ability to support life sciences brands across every stage of their lifecycle, from upfront qualitative and quantitative insights to brand positioning and market access pull-through.
This integrated approach is designed to help life sciences organizations navigate market dynamics, inform critical commercial decisions, and drive measurable impact in patient access and brand performance.
About TJP
Founded in 1972 and recognized as an MM+M Top 100 Agency, TJP, a portfolio company of Renovus Capital, is a patient and market access agency specializing in strategic, creative, digital, and pull through solutions that align strategy, experience, and execution across the life sciences access ecosystem. Additionally, TJP delivers specialized, highly targeted marketing and digital solution offerings for consumer brands.
About Evolution Consulting & Research
Evolution Consulting & Research is a specialized market research consultancy serving global life sciences organizations. Founded by industry veterans, Jim Heasley, Mike Heasley and Jim Cummings, Evolution delivers data-driven qualitative and quantitative insights that help pharmaceutical and biotech manufacturers navigate market dynamics, optimize brand positioning, and inform critical commercial decisions.
About Renovus Capital Partners
Founded in 2010, Renovus Capital Partners is a private equity firm specializing in investments in knowledge and talent industries, including healthcare services, life sciences services, education, and technology services. Renovus partners with founder-led and management-backed businesses to accelerate growth through operational enhancements and strategic add-on acquisitions.
